Hybrid Dissolving Microneedles Incorporating Hyaluronic Acid Microdepots for Pain-free and Long-acting Corticosteroid Therapy
Open Access
- 1 January 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30, 0303
Abstract
Inflammatory skin diseases are chronic conditions characterized by persistent inflammation and disrupted skin barriers, necessitating sustained drug delivery. This study presents a long-acting hybrid dissolving microneedle (DMN) patch incorporating hyaluronic acid (HA)-based microparticle depots (TA@MDepots) for intradermal delivery of triamcinolone acetonide (TA). HA is modified to HA acetate to enhance compatibility with hydrophobic TA, enabling efficient microdepot formulation. These TA@MDepots are integrated into the DMN tip layer using mold-casting, resulting in patches with strong mechanical properties and rapid tip dissolution (<3 min) upon application. In vitro and ex vivo studies demonstrate effective skin penetration, sustained dermal retention, and prolonged TA release. The hybrid patch shows excellent cytocompatibility and significantly reduces tumor necrosis factor-alpha and interleukin-6 levels in activated macrophages. In vivo, the patch outperforms commercial TA ointment in a murine ulcer model by accelerating wound closure, reducing epidermal thickening, and lowering inflammatory cytokine expression, despite a lower TA dosage and fewer applications. Histological analyses confirm skin structure restoration and immune modulation, while systemic toxicity assessments show no adverse effects. This hybrid DMN platform offers a minimally invasive, biocompatible, and patient-friendly strategy for prolonged corticosteroid delivery in chronic inflammatory skin diseases and represents a promising alternative to conventional topical or injectable therapies.Keywords
Funding Information
- Ministry of Education (RS-2025-25441283)
- Ministry of Science and ICT, South Korea (RS-2024-00334037)
- Soonchunhyang University
This publication has 48 references indexed in Scilit:
- Bioprinting for drug screening: A path toward reducing animal testing or redefining preclinical research?Bioactive Materials, 2025
- Advances in Polysaccharide-Based Microneedle Systems for the Treatment of Ocular DiseasesNano-Micro Letters, 2024
- Hyaluronic acid-based dual network hydrogel with sustained release of platelet-rich plasma as a diabetic wound dressingCarbohydrate Polymers, 2023
- High‐Dose Steroid Dissolving Microneedle for Relieving Atopic DermatitisAdvanced Healthcare Materials, 2021
- Microparticle Depots for Controlled and Sustained Release of Endosomolytic NanoparticlesCellular and Molecular Bioengineering, 2019
- Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle PatchesPharmaceutical Research, 2015
- Microneedles for drug and vaccine deliveryAdvanced Drug Delivery Reviews, 2012
- Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesisJournal of Materials Science: Materials in Medicine, 2012
- Preparation and characterization of microspheres based on blend of poly(lactic acid) and poly(ɛ-caprolactone) with poly(vinyl alcohol) as emulsifierArabian Journal of Chemistry, 2012
- Control of encapsulation efficiency and initial burst in polymeric microparticle systemsArchives of Pharmacal Research, 2004